「no」の検索結果
166件：61～65件目を表示
-
お知らせ | 千寿製薬株式会社
in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） December 22, 2025 Obtained manufact...
https://www.senju.co.jp/english/news/ -
お知らせ | 千寿製薬株式会社
in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） December 22, 2025 Obtained manufact...
http://www.senju.co.jp/english/news/ -
产品介绍 | 海外活动 | 千寿制药株式会社
CATALIN Senju Poland Sp. z o.o. CATALIN PRATTACK Senju Poland Sp. z o.o. NIFLAN NETENAX SIFI S.p.A. Not marketed in JP NETAXEN SIFI S.p.A. Not marketed in JP ETAFRY SIFI S.p.A. Not marketed in JP 拉脱维亚...
https://www.senju.co.jp/chinese/global/world.html -
产品介绍 | 海外活动 | 千寿制药株式会社
CATALIN Senju Poland Sp. z o.o. CATALIN PRATTACK Senju Poland Sp. z o.o. NIFLAN NETENAX SIFI S.p.A. Not marketed in JP NETAXEN SIFI S.p.A. Not marketed in JP ETAFRY SIFI S.p.A. Not marketed in JP 拉脱维亚...
http://www.senju.co.jp/chinese/global/world.html -
Mytear HARD LENS WETTING SOLUTION | OTC Products, etc. | Products | SENJU Pharmaceutical
se this product only under the direction and supervision of a parent or other responsible adult. Do not touch the tip of the bottle to contact lenses or fingers. (If dirt or other foreign matter, etc....
https://www.senju.co.jp/english/products/wettingsolution.html